Dong-A Pharm. Co., Ltd.
Records under this name other than the patents Dong-A Pharm. Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Dong-A Pharm. Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,329,191 | Three-branched polyethylene glycol-G-CSF conjugate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,148,386 | Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,420,676 | Novel Oxazolidinone Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,796,286 | Agent for treatment of liver diseases containing pyrazolopyrimidinone derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,816,379 | Novel Oxazolidinone Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 9,163,043 | Novel Oxazolidinone Derivatives Term ended Term ended Dec 17, 2024 · High confidence | Term ended | Term ended Dec 17, 2024 | High confidence |
| US 6,689,779 | Oxazolidinone derivatives and a process for the preparation thereof Term ended Term ended Nov 27, 2022 · From the USPTO record | Term ended | Term ended Nov 27, 2022 | From the USPTO record |
| US 6,844,436 | Preparing pyrazolopyrimidinone derivatives for the treatment of impotence Formerly held Term ended Term ended May 23, 2021 · From the USPTO record | Term ended | Term ended May 23, 2021 | From the USPTO record |
| US 6,583,147 | Pyrazolopyrimidinone derivatives for the treatment of impotence Formerly held Term ended Term ended May 9, 2021 · From the USPTO record | Term ended | Term ended May 9, 2021 | From the USPTO record |
| US 8,203,011 | 3′,4′,5-trimethoxy flavone derivatives as stimulant of mucus secretion, method for the same, and pharmaceutical composition comprising the same Lapsed on the fee record Ended Jun 19, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2020 | From the USPTO record |